Success Metrics

Clinical Success Rate
100.0%

Based on 11 completed trials

Completion Rate
100%(11/11)
Active Trials
7(37%)
Results Posted
55%(6 trials)

Phase Distribution

Ph phase_1
2
11%
Ph phase_2
5
26%
Ph phase_4
6
32%
Ph phase_3
3
16%
Ph not_applicable
2
11%

Phase Distribution

2

Early Stage

5

Mid Stage

9

Late Stage

Phase Distribution18 total trials
Phase 1Safety & dosage
2(11.1%)
Phase 2Efficacy & side effects
5(27.8%)
Phase 3Large-scale testing
3(16.7%)
Phase 4Post-market surveillance
6(33.3%)
N/ANon-phased studies
2(11.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

11 of 11 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

7

trials recruiting

Total Trials

19

all time

Status Distribution
Active(7)
Completed(11)
Other(1)

Detailed Status

Completed11
Active, not recruiting4
Recruiting3
unknown1

Development Timeline

Analytics

Development Status

Total Trials
19
Active
7
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (11.1%)
Phase 25 (27.8%)
Phase 33 (16.7%)
Phase 46 (33.3%)
N/A2 (11.1%)

Trials by Status

unknown15%
completed1158%
active_not_recruiting421%
recruiting316%

Recent Activity

Clinical Trials (19)

Showing 19 of 19 trials
NCT06148025Phase 4

Antibiotics and Vaccine Immune Responses Study

Recruiting
NCT04269265Phase 1

The Effect of Inflammation and Damage to Lymph Node Structures on Durable Protective Immunity Following Yellow Fever Vaccination

Completed
NCT00694655Phase 4

Human Immune Responses to Yellow Fever Vaccination

Completed
NCT04142086Phase 1

Dose-ranging Study of an Investigational Yellow Fever Candidate Vaccine in Adults

Completed
NCT06879327Phase 2

Infant Malaria Vaccine Schedule Optimization

Recruiting
NCT04942210Phase 2

Study on an Investigational Yellow Fever Vaccine Compared With YF-VAX in Adults in the USA

Active Not Recruiting
NCT05011123Phase 2

Study on an Investigational Yellow Fever Vaccine Compared With Stamaril in Adults in Europe and Asia

Active Not Recruiting
NCT01290055Phase 4

Turnover of Antigen Specific Lymphocytes and Monocytes After Immunization With the 17D Yellow Fever Vaccine

Completed
NCT04083430Phase 4

Cytotoxicity of Yellow Fever Specific CD8 T Cells Following YF-17D Vaccination

Active Not Recruiting
NCT06213506Phase 2

A Study on the Safety, Reactogenicity, and Immune Response to the GVGH iNTS-GMMA Vaccine Against Invasive Nontyphoidal Salmonella in Adults, Children, and Infants

Recruiting
NCT05374317Phase 4

Study of the Safety and Immunogenicity of Reduced Doses of the US Yellow Fever Vaccine

Completed
NCT05901454Not Applicable

Yellow Fever Human Infection Model With YF-17D

Unknown
NCT02555072Phase 4

Immunity Period After One Dose of Yellow Fever Vaccine in Adults and Children (Paraiba Study)

Active Not Recruiting
NCT01436396Phase 3

Study of Yellow Fever Vaccine Administered With Tetravalent Dengue Vaccine in Healthy Toddlers

Completed
NCT03458780

Yellow Fever Immune Response at Single Cell Resolution

Completed
NCT01345240Phase 3

Study to Evaluate Immunogenicity of the Hepatitis B Antigen of the GSK Biologicals' Candidate Malaria Vaccine (257049)

Completed
NCT01943305Phase 2

The Role of Pre-existing Cross-reactive Antibodies in Determining the Efficacy of Vaccination in Humans

Completed
NCT01765413Not Applicable

Training Study to Characterize Biomarkers to Chickenpox and Yellow Fever Vaccines

Completed
NCT01466387Phase 3

A Phase 3b, Randomized, Open-Label Study to Evaluate the Safety and Immunogenicity of Select Travel Vaccines When Administered Concomitantly With MenACWY in Adults

Completed

All 19 trials loaded

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
19